Literature DB >> 7897145

Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?

E R McFadden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7897145     DOI： 10.1016/s0091-6749(95)70166-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Low dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  J C Kips; R A Pauwels
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Concerns regarding the current use of beta-agonists in the therapy of asthma.

Authors:  G Aberg; J Costello
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 3.  The pharmacokinetics of levosalbutamol: what are the clinical implications?

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

4.  Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs.

Authors:  Su Guan; Chun-Yun Hu; Meng-Ying He; Ying-Ying Yang; Yu-Xin Tang; Jie-di Chen; Li-Jie Huang; Wen Tan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-10-04       Impact factor: 2.441

Review 5.  Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network.

Authors:  Loren C Denlinger; Christine A Sorkness; Vernon M Chinchilli; Robert F Lemanske
Journal:  J Allergy Clin Immunol       Date:  2006-12-04       Impact factor: 10.793

Review 6.  Choosing therapy for childhood asthma.

Authors:  R F Lemanske
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 8.  Recovery from bronchoconstriction and bronchodilator tolerance.

Authors:  Sarah Haney; Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 9.  Asthma therapies revisited: what have we learned?

Authors:  Robert F Lemanske
Journal:  Proc Am Thorac Soc       Date:  2009-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.